Abdo A. Elfiky
Infectious Diseases · 2020
A researcher in the Science corpus: 3 papers; trusts 37 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 21 citations into it; #361 of 589 by trust here, #426 by citations
- Molecular Biology — 18 citations into it
- Materials Chemistry — 15 citations into it
- Computational Theory and Mathematics — 13 citations into it
- Computational Chemistry & Drug Discovery — 9 citations into it
- Computational Biology & Bioinformatics — 8 citations into it
- Modeling and Simulation — 5 citations into it
Whom Abdo A. Elfiky trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- James J. P. Stewart
- Arthur J. Olson
- Marco Biasini
- Helen M. Berman
- A. Ward
- Garrett M. Morris
- Eric F. Pettersen
- Stefan Bienert
- James C. Phillips
- Christopher J. Williams
Who trusts Abdo A. Elfiky overall
Papers from Abdo A. Elfiky's perspective
Ordered by how strongly the researchers Abdo A. Elfiky trusts endorse each paper. Same corpus, a different order for every researcher.
- Announcing the worldwide Protein Data Bank
- UCSF Chimera—A visualization system for exploratory research and analysis
- AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading
- SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
- The Protein Data Bank
- High-resolution structure of a retroviral protease folded as a monomer
- The Protein Data Bank.
- Basic local alignment search tool.
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data
Their papers
- Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 (2020) — 628 citations
- SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective (2020) — 311 citations
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study (2020) — 804 citations